Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy-Reference-Cited by-同舟云学术

Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy

Published:2005-02-17 Issue:5 Volume:272 Page:1124-1135
ISSN:1742-464X
Container-title:FEBS Journal
language:en
Short-container-title:

Author:

Floreani Maura,Napoli Eleonora,Martinuzzi Andrea,Pantano Giorgia,De Riva Valentina,Trevisan Roberta,Bisetto Elena,Valente Lucia,Carelli Valerio,Dabbeni-Sala Federica

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-4658.2004.04542.x/fullpdf

Reference48 articles.

1. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy;Wallace;Science,1988

2. Mitochondrial dysfunction as a cause of optic neuropathies;Carelli;Prog Retin Eye Res,2004

3. The enigmatic relationship between mitochondrial dysfunction and Leber's hereditary optic neuropathy;Brown;J Neurol Sci,1999

4. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype;Carelli;Neurology,1997

5. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy;Carelli;Ann Neurol,1999

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired mitochondrial morphological plasticity and failure of mitophagy associated with the G11778A mutation of LHON;Biochemical and Biophysical Research Communications;2024-08

2. Galactose-replacement unmasks the biochemical consequences of the G11778A mitochondrial DNA mutation of LHON in patient-derived fibroblasts;Experimental Cell Research;2024-06

3. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy;Cell Reports Medicine;2024-02

4. Oxidative stress in the eye and its role in the pathophysiology of ocular diseases;Redox Biology;2023-12

5. Toxic Medications in Mitochondrial Optic Neuropathies;Advances in Ophthalmology and Optometry;2023-08